Do sluggish cognitive tempo symptoms predict response to methylphenidate in patients with attention-deficit/hyperactivity disorder-inattentive type?

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 4, 2009, Pages 461-465

  Ludwig, Henrique T ^a   Matte, Breno ^a   Katz, Betina ^a   Rohde, Luis Augusto ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR CHECKLIST; CLINICAL ASSESSMENT; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESPONSE; EVENING DOSAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PREDICTION; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; SLUGGISH COGNITIVE TEMPO SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 69549111413     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0115     Document Type: Article

References (24)

1. Achenbach T: Manual for the Child Behavior Checklist: 4-18 and 1991 Profile. Burlington (Vermont): University of Vermont, Department of Psychiatry, 1991.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. (DSM-III). Washington (DC): American Psychiatric Association, 1980.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
4. Barkley RA, DuPaul GJ, McMurray MB: Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychology 58:775-789, 1990.
5. Capdevila-Brophy C, Artigas-Pallarés J, Obiols-Llandrich JE: [Sluggish cognitive tempo: Symptoms of predominantly inattentive attention deficit hyperactivity disorder or a new clinical entity?]. Rev Neurol 42(Suppl 2):S127-S134, 2006.
6. Frick PJ, Lahey BB, Applegate B, Kerdyck L, Ollendick T, Hynd GW, Garfinkel B, Greenhill L, Biederman J, Barkley R, McBurnett K, Newcorn J, Waldman I: DSM-IV field trials for the disruptive behavior disorders: Symptom utility estimates. J Am Acad Child Adolesc Psychiatry 33:529-539, 1994. (Pubitemid 24133072)
7. Hartman CA, Willcutt EG, Rhee SH, Pennington BF: The relation between sluggish cognitive tempo and DSM-IV ADHD. J Abnorm Child Psychol. 32:491-503, 2004.
8. Jensen PS, Martin D, Cantwell DP: Comorbidity in ADHD: Implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry 36:1065-1079, 1997. (Pubitemid 27337657)
9. Lahey BB, Carlson CL: Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry 37:695-702, 1998. (Pubitemid 28304532)
10. McBurnett K, Pfiffner LJ, Frick PJ: Symptom properties as a function of ADHD type: An argument for continued study of sluggish cognitive tempo. J Abnorm Child Psychol 29:207-213, 2001. (Pubitemid 33745806)
11. Polanczyk G, Eizirik M, Aranovich V, Denardin D, da Silva TL, da Conceicao TV, Pianca TG, Rohde LA: Interrater agreement for the schedule for affective disorders and schizophrenia epidemiological version for school-age children (K-SADS-E). Rev Bras Psiquiatria 25:87-90, 2003. (Pubitemid 36995302)
12. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942-948, 2007a. (Pubitemid 46972911)
13. Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA: Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64:218-224, 2007b. (Pubitemid 46220779)
14. Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmontede-Abreu P, Faraone SV, Rohde LA: Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder? J Clin Psychiatry 68:1109-1116, 2007.
15. Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 126:983-987, 1970.
16. Rohde LA: Is there a need to reformulate attention deficit hyperactivity disorder criteria in future nosologic classifications? Child Adolesc Psychiatry Clin N Am 17:405-420, 2008.
17. Rohde LA, Szobot C, Polanczyk G, Martins S, Schmidt M, Tramontina S: ADHD in a diverse culture: Do research and clinical findings support the notion of a cultural construct for the disorder? Biol Psychiatry 57:1436-1441, 2005.
18. Schmitz M, Denardin D, Silva TL, Pianca T, Roman T, Hutz MH, Faraone SV, Rohde LA: Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry 60:1028-1033, 2006a. (Pubitemid 44647211)
19. Schmitz M, Denardin D, Silva TL, Pianca T, Hutz MH, Faraone SV, Rohde LA: Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: A case-control study. J Am Acad Child Adolesc Psychiatry 45:1338-1345, 2006b. (Pubitemid 44665451)
20. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432, 1996. (Pubitemid 126418605)
21. Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M: Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168-179, 2001. (Pubitemid 32111020)
22. Todd RD, Rasmussen ER, Wood C, Levy F, Hay DA: Should sluggish cognitive tempo symptoms be included in the diagnosis of attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 43:588-597, 2004.
23. Wechsler D: WISC-III/Manual. New York: The Psychological Corporation, 1991.
24. Woo BS, Rey JM: The validity of the DSM-IV subtypes of attention-deficit/hyperactivity disorder. Aust N Z J Psychiatry 39: 344-353, 2005. (Pubitemid 40740306)